endpoint assays for the characterization of rare and therapy resistant cells in cancer
Published 3 years ago • 316 plays • Length 54:30Download video MP4
Download video MP3
Similar videos
-
42:10
detection of mutations from liquid biopsies - applications in cancer diagnostics
-
20:43
using cell based assays in the development of efficacious cancer therapies.
-
46:47
tracy stockley - variant detection in cell-free dna from nsclc using ngs
-
56:50
gold standards and innovative processes for dc research in immuno-oncology
-
1:02:00
mark landers - real-time profiling of tumor heterogeneity in metastatic disease
-
52:06
advances and trends enabling the growth of immune-based cancer research and therapeutics
-
1:00:11
early ctdna molecular response enhanced through integrated analyses of cell free dna and matched...
-
22:42
the inhibitory role of specific macrophages in rcc
-
25:17
the clinical application, development & validation of cell free dna assays/platforms
-
4:06
the use of ctdna assays in patients with cancer
-
53:01
the biomarker to companion diagnostic continuum a road map for the delivery of precision medicine
-
57:12
brainmap: cell tracking: a noninvasive assay for understanding cancer cells in the brain
-
3:38
how genomic testing helped this appendiceal cancer patient
-
57:21
clinical utility of a novel assay for tracking tumor burden in merkel cell carcinoma
-
0:15
activated t cell attacks a cancer cell
-
51:49
keynote presentation: it is time for time (tumor immune microenvironment) in experimental and...
-
1:06:52
unraveling the complexities of immuno oncology with 3d biology™ technology
-
42:10
detection of mutations from liquid biopsies - applications in cancer diagnostics
-
56:51
define challenges of tissue-based biomarker development for immuno-oncology therapy